Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 4, 2019
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significanceSimon Pernot, Magali Terme, Nina Radosevic-Robin, et al.
Gastroenterology|November 29, 2024
ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France CohortsCamilla Pilati, Audrey Soulabaille, Claire Gallois, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2021
Prognostic factors of colorectal cancer patients with brain metastasesPauline Roussille, Marie Auvray, Damien Vansteene, et al.
The New England Journal of Medicine|May 13, 2011
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancerThierry Conroy, Françoise Desseigne, Marc Ychou, et al.
Clinical Lung Cancer|February 28, 2019
Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study ProtocolBenjamin Levy, Luis Paz-Ares, Jaafar Bennouna, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancerKeunchil Park, Jaafar Bennouna, Michael Boyer, et al.
Lancet (London, England)|August 12, 2011
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trialElisabeth Quoix, Gérard Zalcman, Jean-Philippe Oster, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2016
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung CancerDavid R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2019
The inhibitory receptor CD94/NKG2A on CD8<sup>+</sup> tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpressionJuliette Eugène, Nicolas Jouand, Kathleen Ducoin, et al.
Ebiomedicine|August 5, 2019
The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancerDelphine Le Corre, Alexandre Ghazi, Ralyath Balogoun, et al.
Pageof 17